Ectopic visceral fat: a clinical and molecular perspective on the cardiometabolic risk
Patrick Mathieu1, Marie-Chloé Boulanger, Jean-Pierre Després
1Institut de Cardiologie et de Pneumologie de Québec/Quebec Heart and Lung Institute, 2725 Chemin Ste-Foy, Québec, QC, G1V-4G5, Canada, patrick.mathieu@chg.ulaval.ca.
Insights
Ectopic visceral fat accumulation is increasingly linked to cardiovascular diseases (CVDs) beyond coronary artery disease. Understanding these molecular links is crucial for managing residual risk and improving patient outcomes.
Area of Science:
- Cardiovascular Medicine
- Metabolic Disorders
- Medical Imaging
Background:
- Cardiovascular diseases (CVDs) remain a primary cause of global mortality.
- Despite reduced smoking rates and focus on classical risk factors, a significant residual risk for CVDs persists.
- Ectopic visceral fat accumulation is recognized as a key contributor to metabolic dysfunction and cardiovascular disorders.
Purpose of the Study:
- To review the molecular mechanisms connecting ectopic fat accumulation to the development of various CVDs.
- To explore the translational relevance of these molecular processes in clinical observations.
- To highlight emerging evidence on ectopic fat's role in conditions beyond coronary artery disease.
Main Methods:
- Comprehensive literature review of imaging studies and molecular research.
- Analysis of data spanning over two decades.
- Translational approach linking pathobiology to clinical observations.
Main Results:
- Ectopic visceral fat is strongly associated with metabolic dysfunctions contributing to CVDs.
- Established link between visceral fat and coronary artery disease (CAD).
- Emerging evidence implicates ectopic fat in calcific aortic valve disease (CAVD), atrial fibrillation, and left ventricular dysfunction.
Conclusions:
- Ectopic fat accumulation is a critical, yet often overlooked, factor in the pathogenesis of diverse cardiovascular diseases.
- Understanding the molecular pathways is essential for developing novel therapeutic strategies targeting residual cardiovascular risk.
- A translational approach integrating molecular insights with clinical data is vital for advancing cardiovascular medicine.
Abstract:
Worldwide, cardiovascular diseases (CVDs) are a leading cause of mortality. While in many westernized societies there has been a decrease prevalence of smoking and that a special emphasis has been put on the urgency to control the, so called, classical risk factors, it is more and more recognized that there remains a residual risk, which contributes to the development of CVDs. Imaging studies conducted over two decades have highlighted that the accumulation of ectopic visceral fat is associated with a plethora of metabolic dysfunctions, which have complex and intertwined interactions and participate to the development/progression/events of many cardiovascular disorders. The contribution of visceral ectopic fat to the development of coronary artery disease (CAD) is now well established, while in the last several years emerging evidence has pointed out that accumulation of harmful ectopic fat is associated with other cardiovascular disorders such as calcific aortic valve disease (CAVD), atrial fibrillation and left ventricular dysfunction. We review herein the key molecular processes linking the accumulation of ectopic fat to the development of CVDs. We have attempted, whenever possible, to use a translational approach whereby the pathobiology processes are linked to clinical observations.
More Related Videos
07:24Assessment of Human Adipose Tissue Microvascular Function Using Videomicroscopy
Published on: September 29, 2017
06:56Author Spotlight: The Significance of Isolation, Culture, and Adipogenic Induction of SVF-Derived Preadipocytes from Mouse Perivascular Adipose Tissue
Published on: July 21, 2023
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Hypodermis
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
